Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) is a highly promising antitumor agent that specifically induces tumor cell apoptosis without killing normal cells and binding with apoptosis receptors [1–3]. Here, TNFSF10 is linked to neoplasm.